Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 2, 2011, Pages 137-144

  Fransson, Per ^a   Widmark, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Erectile dysfunction; Patient reported outcome; Prostate cancer; Radiotherapy; Sexual function

Indexed keywords

ARTICLE; CANCER HORMONE THERAPY; CONTROLLED STUDY; DISEASE COURSE; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; RISK FACTORS; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 79952043535     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.01.001     Document Type: Article

References (33)

1. McCammon K.A., Kolm P., Main B., et al. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999, 54:509-516.
2. Turner S.L., Adams K., Bull C.A., et al. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology 1999, 54:124-129.
3. van der Wielen G.J., van Putten W.L., Incrocci L. Sexual function after three-dimensional conformal radiotherapy for prostate cancer: Results from a dose-escalation trial. Int J Radiat Oncol Biol Phys 2007, 68:479-484.
4. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999, 85:2460-2468.
5. Incrocci L., Slob A.K., Levendag P.C. Sexual (dys)function after radiotherapy for prostate cancer: A review. Int J Radiat Oncol Biol Phys 2002, 52:681-693.
6. Roach M., Chinn D.M., Holland J., et al. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996, 35:869-874.
7. Wespes E., Amar E., Hatzichristou D., et al. Guidelines on erectile dysfunction. Eur Urol 2002, 41:1-5.
8. Davidson S.E., Burns M.P., Routledge J.A., et al. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 2003, 69:195-200.
9. Salonia A., Gallina A., Briganti A., et al. Remembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. J Sex Med 2008, 5:677-683.
10. Fransson P. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer. Acta Oncol 2005, 44:355-361.
11. Salonia A., Zanni G., Gallina A., et al. Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol 2006, 50:360-365.
12. Fransson P., Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group. Cancer 1996, 78:1066-1078.
13. Fransson P., Widmark A. Late side effects unchanged 4 to 8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls. Cancer 1999, 85:678-688.
14. Widmark A., Fransson P., Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994, 74:2520-2532.
15. Fransson P., Tavelin B., Widmark A. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects. Support Care Cancer 2001, 9:187-198.
16. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, five-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11:319-326.
17. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial. Lancet 1999, 353:267-272.
18. al-Abany M., Helgason A.R., Cronqvist A.K., et al. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncologica 2002, 41:532-542.
19. Brown M.W., Brooks J.P., Albert P.S., et al. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma. Prostate Cancer Prostatic Dis 2007, 10:189-193.
20. Namiki S., Ishidoya S., Tochigi T., et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol 2006, 36:224-230.
21. Green H.J., Pakenham K.I., Headley B.C., et al. Quality of life compared during pharmacological treatments and clinical monitoring for nonlocalized prostate cancer: a randomized controlled trial. BJU Int 2004, 93:975-979.
22. Valicenti R.K., Winter K., Cox J.D., et al. RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?. Int J Radiat Oncol Biol Phys 2003, 57:614-620.
23. Schover L.R., Fouladi R.T., Warneke C.L., et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 2002, 95:2397-2407.
24. Mols F., Korfage I.J., Vingerhoets A.J., et al. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: A population-based study. Int J Radiat Oncol Biol Phys 2008, 73:30-38.
25. Penson D.F., Litwin M.S., Aaronson N.K. Health related quality of life in men with prostate cancer. J Urol 2003, 169:1653-1661.
26. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol 1998, 159:1988-1992.
27. Litwin M.S., McGuigan K.A. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol 1999, 17:2882-2888.
28. van der Wielen G.J., Mulhall J.P., Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007, 84:107-113.
29. Lewis R.W., Fugl-Meyer K.S., Bosch R., et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004, 1:35-39.
30. Houterman S., Janssen-Heijnen M.L., Verheij C.D., et al. Greater influence of age than comorbidity on primary treatment and complications of prostate cancer patients: An in-depth population-based study. Prostate Cancer Prostatic Dis 2006, 9:179-184.
31. Basaria S., Lieb J., Tang A.M., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf.) 2002, 56:779-786.
32. al-Abany M., Steineck G., Agren Cronqvist A.K., et al. Improving the preservation of erectile function after external beam radiation therapy for prostate cancer. Radiother Oncol 2000, 57:201-206.
33. Stock R.G., Kao J., Stone N.N. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001, 165:436-439.